Skin Research and Technology

Papers
(The H4-Index of Skin Research and Technology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Back Cover34
Cover Image34
Expression of interleukin‐1β, interleukin‐4, interferon‐γ and tumour necrosis factor α in different tissue in a dinitrochlorobenzene‐induced ear swelling test in mice27
Ultrasound: Assessment of breast dermal thickness: Reliability, responsiveness to change, and relationship to patient‐reported outcomes25
24
Multivariate logistic regression analysis of poor prognosis of dermatomyositis and clinical value of ferritin/Kl‐6 in predicting prognosis22
The relevance and accuracy of an AI algorithm‐based descriptor on 23 facial attributes in a diverse female US population22
Effects of Siegesbeckia herba extract against particulate matter 10 (PM10) in skin barrier‐disrupted mouse models20
Modeling of global skin aging indices among Caucasian and Asian women20
Key genes and immune infiltration patterns and the clinical implications in psoriasis patients20
Environmental exposures and chronic inflammatory dermatoses: Preventive and therapeutic strategies19
Yellowness in skin complexion: Analysis of self‐perception of women in China evaluated against clinical parameters of yellowness18
Causal relationship between inflammatory skin diseases and immunoglobulin A nephropathy: A Mendelian randomization and enrichment analysis study18
Correlation of non‐invasive psycho‐physiological and skin‐physiological measures17
Examining the causal association between psoriasis and bladder cancer: A two‐sample Mendelian randomization analysis17
Volumizing threads and hyaluronic acid filler for lip augmentation17
Ultrasonography of cutaneous nodular pseudolymphoma at 18 and 71 MHz17
Randomised, split‐face study of a dermocosmetic cream containing Sphingobioma xenophaga extract and Neurosensine® in subjects with rosacea associated with erythema and sensitive skin17
0.15766406059265